| Record ID | marc_loc_2016/BooksAll.2016.part26.utf8:77985400:1135 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part26.utf8:77985400:1135?format=raw |
LEADER: 01135pam a2200313 a 4500
001 97052408
003 DLC
005 19980901155517.0
008 971230s1998 gw b 001 0 eng c
010 $a 97052408
020 $a3540640304 (hardcover : alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC261$b.R35 vol. 148$aRC270.8
060 10 $aW1 RE106P v.148 1998$aQZ 266 N572a 1998
082 00 $a616.99/4 s$a338.4/361699406$221
100 1 $aNeymark, Niels.
245 10 $aAssessing the economic value of anticancer therapies /$cN. Neymark.
246 3 $aAssessing the economic value of anti-cancer therapies
260 $aBerlin ;$aNew York :$bSpringer,$cc1998.
300 $axi, 285 p. ;$c25 cm.
440 0 $aRecent results in cancer research,$x0080-0015 ;$v148
504 $aIncludes bibliographical references (p. [277]-285).
650 0 $aCancer$xTreatment$xEconomic aspects.
650 0 $aCancer$xTreatment$xCost effectiveness.
650 0 $aMedical care, Cost of.
650 12 $aNeoplasms$xtherapy.
650 22 $aCost-Benefit Analysis$xmethods.
650 22 $aNeoplasms$xeconomics.
650 22 $aHealth Care Costs.